Page 8 of lupin

Lupin, Lupin Limited, HIV/AIDS, drugs, generic drugs, healthcare news, pharma news,

USFDA approves Lupin’s tablets for Hepatitis B infection treatment

Tenofovir Alafenamide Tablets, 25 mg, (RLD Vemlidy) had estimated annual sales of USD 531 million in the U.S. (IQVIA MAT…

March 31, 2023 15:25 IST

CDSCO, drug alert, DCGI, spurious drugs, drug quality, healthcare news, pharma news

Rating: buy; Lupin to focus more on speciality segment for future growth

Material improvement in Ebitda to be driven by topline growth

February 28, 2023 02:00 IST

Lupin launches generic tablets for mental disorders in United States

Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales…

February 21, 2023 14:46 IST

Lupin, Lupin Limited, Vizag, EIR, healthcare news, pharma news,

Lupin reports decline in profit by 72 percent to Rs. 153 crore in Q3FY23

The consolidated revenue advanced albeit marginally by 3.9 percent year-on-year (YoY) to Rs 4,322 crore in Q3FY23.

February 10, 2023 15:25 IST

USFDA tentatively approves Lupin’s HIV/AIDS tablets

The tentative approval has been granted under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

January 31, 2023 14:25 IST

Lupin, Lupin Digital Health, Lupin Limited, Healthcare news, pharma news,

Lupin launches its digital therapeutics solution for cardiac care

The company claims that LYFE offers expert intervention in the form of dedicated care managers, health coaches and nutritionists.

January 24, 2023 17:29 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

Lupin launches generic version of Novartis’ heart failure drug in India

Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…

January 18, 2023 18:42 IST

USFDA tentatively approves Lupin’s two HIV/AIDS tablets

Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of USD 666 million in the U.S.…

January 16, 2023 14:52 IST

USFDA approves Lupin’s generic heart disorder tablets

Prasugrel Tablets USP, 5 mg and 10 mg, (RLD Effient) had estimated annual sales of USD 18 million in the…

January 10, 2023 17:08 IST

Lupin, Lupin Limited, Asthma, fixed-dose triple drug combination, health news, pharma news,

Lupin launches fixed-dose triple drug combination to treat uncontrolled asthma

According to the pharma major, DIFIZMA will help in the management of inadequately controlled asthma by improving lung function, providing…

January 5, 2023 13:15 IST

Lupin, Lupin Limited, Regional Reference Laboratory, health news, pharma news, diagnostics news,

Lupin Diagnostics launches Regional Reference Laboratory in Indore

These labs are equipped with qualified clinical experts and automated, streamlined processes so patients can make informed decisions about their…

December 21, 2022 17:23 IST

Novartis, Heart failure, patent expiry, Indian cardiac market, healthcare news, pharma news,

Some Biosimilar products help in increasing neutrophil counts of cancer patients, which helps to boost the immune system and reduce…

December 18, 2022 20:41 IST

Lupin, Lupin limited, Lupin appointments, generic business, health news, pharma news,

Lupin appoints Spiro Gavaris as President of U.S. Generics business

Spiro joins Lupin with significant experience in the branded, generic and biotech industries, the company stated.

December 9, 2022 17:05 IST

Lupin launches generic version of Horizon Pharma’s anti-inflammatory drug in United States

According to IQVIA MAT October 2022, Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of USD…

December 9, 2022 15:16 IST

Lupin launches anti-seizure tablets in United States

According to IQVIA MAT October 2022, Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the…

December 5, 2022 14:51 IST

Lupin’s Brazilian subsidiary, MedQuimica acquires rights to 9 brands from Bausch Health

This move reinforces our commitment to making healthcare solutions accessible to all patients, the company claimed.

November 28, 2022 18:14 IST

Nevertheless, at current valuations, closure/divestment of underutilised assets poses an upside risk. Retain ADD with a raised fair value of Rs 750.

Lupin Rating: Add | Margin recovery set to continue in the near term

The company expects India to grow in double digits in FY2024

November 14, 2022 04:50 IST

Lupin’s revenue rises to Rs. 4,145 crore in Q2; Net profit of Rs. 130 crore

Meanwhile, global API Sales for Q2 FY2023 were INR 2,499 mn, down 2 percent as compared to INR 2,551 mn…

November 10, 2022 11:10 IST

Related News

Inflation calculator: What will be the value of Rs 1 crore after 10 years?

FedEx hires surge in H-1B workers as American layoffs continue

FedEx hires hundreds of H-1B workers, fires US staff; Indian-origin CEO questioned

Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang tells teens how to build a lucrative tech future

8th Pay Commission Rules: No DA increase, pension revision for central government pensioners?

8th Pay Commission News: No DA increase, pension revision for central government pensioners? Fact checked

An employee claimed that his team lead asked for medical documents despite him being on approved medical leave, adding that Indian corporate culture needs to recognise that medical leave is neither a “loophole nor an ego challenge”, but a necessity that deserves respect.

‘Why is recovery treated like favour?’ Employee claims company chased him for documents despite approved medical leave

From Polls, PM Modi to Adani and Op Sindoor: Why MHA sent 91 takedown notices to X?

India News27 min ago

In a span of 20 months, the Home Ministry of Home Affairs (MHA) sent 91 takedown notices to X Corp, citing over 1,100 URLs that violated public order, targeted political figures, and spread misinformation during the 2024 Lok Sabha elections. The report also highlighted spikes in takedown notices during Operation Sindoor and the Pahalgam terror attack.

View all shorts